[HTML][HTML] Anti-inflammatory treatment of COVID-19 pneumonia with tofacitinib alone or in combination with dexamethasone is safe and possibly superior to …
ME Hayek, M Mansour, H Ndetan, Q Burkes… - … : Innovations, Quality & …, 2021 - Elsevier
Objective To explore the survival benefit of tofacitinib in addition to dexamethasone in
hospitalized patients treated for coronavirus disease 2019 (COVID-19)–related pneumonia …
hospitalized patients treated for coronavirus disease 2019 (COVID-19)–related pneumonia …
Anti-Inflammatory Treatment of COVID-19 Pneumonia With Tofacitinib Alone or in Combination With Dexamethasone is Safe and Possibly Superior to …
ME Hayek, M Mansour, H Ndetan… - … quality & outcomes, 2021 - pubmed.ncbi.nlm.nih.gov
Objective To explore the survival benefit of tofacitinib in addition to dexamethasone in
hospitalized patients treated for coronavirus disease 2019 (COVID-19)-related pneumonia …
hospitalized patients treated for coronavirus disease 2019 (COVID-19)-related pneumonia …
Anti-Inflammatory Treatment of COVID-19 Pneumonia With Tofacitinib Alone or in Combination With Dexamethasone is Safe and Possibly Superior to …
ME Hayek, M Mansour, H Ndetan, Q Burkes… - … Innovations, Quality & …, 2021 - europepmc.org
Anti-Inflammatory Treatment of COVID-19 Pneumonia With Tofacitinib Alone or in Combination
With Dexamethasone is Safe and Possibly Superior to Dexamethasone as a Single Agent in a …
With Dexamethasone is Safe and Possibly Superior to Dexamethasone as a Single Agent in a …
[HTML][HTML] Anti-Inflammatory Treatment of COVID-19 Pneumonia With Tofacitinib Alone or in Combination With Dexamethasone is Safe and Possibly Superior to …
ME Hayek, M Mansour, H Ndetan… - … Innovations, Quality & …, 2021 - ncbi.nlm.nih.gov
Anti-Inflammatory Treatment of COVID-19 Pneumonia With Tofacitinib Alone or in Combination
With Dexamethasone is Safe and Possibly Superior to Dexamethasone as a Single Agent in …
With Dexamethasone is Safe and Possibly Superior to Dexamethasone as a Single Agent in …
[HTML][HTML] Anti-Inflammatory Treatment of COVID-19 Pneumonia With Tofacitinib Alone or in Combination With Dexamethasone is Safe and Possibly Superior to …
ME Hayek, M Mansour, H Ndetan… - … , Quality & Outcomes, 2021 - mcpiqojournal.org
Objective To explore the survival benefit of tofacitinib in addition to dexamethasone in
hospitalized patients treated for coronavirus disease 2019 (COVID-19)–related pneumonia …
hospitalized patients treated for coronavirus disease 2019 (COVID-19)–related pneumonia …